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Abstract
Background: Chronic Kidney Disease (CKD) patients frequently develop life-impairing bone mineral disorders.
Despite the reported impact of exercise on bone health, systematic reviews of the evidence are lacking. This review
examines the association of both physical activity (PA) and the effects of different exercise interventions with bone
outcomes in CKD.
Methods: English-language publications in EBSCO, Web of Science and Scopus were searched up to May 2019,
from which observational and experimental studies examining the relation between PA and the effect of regular
exercise on bone-imaging or -outcomes in CKD stage 3–5 adults were included. All data were extracted and
recorded using a spreadsheet by two review authors. The evidence quality was rated using the Cochrane risk of
bias tool and a modified Newcastle-Ottawa scale.
Results: Six observational (4 cross-sectional, 2 longitudinal) and seven experimental (2 aerobic-, 5 resistance-exercise
trials) studies were included, with an overall sample size of 367 and 215 patients, respectively. Judged risk of bias
was low and unclear in most observational and experimental studies, respectively. PA was positively associated with
bone mineral density at lumbar spine, femoral neck and total body, but not with bone biomarkers. Resistance
exercise seems to improve bone mass at femoral neck and proximal femur, with improved bone formation and
inhibited bone resorption observed, despite the inconsistency of results amongst different studies.
Conclusions: There is partial evidence supporting (i) a positive relation of PA and bone outcomes, and (ii) positive
effects of resistance exercise on bone health in CKD. Prospective population studies and long-term RCT trials
exploring different exercise modalities measuring bone-related parameters as endpoint are currently lacking.
Keywords: Physical activity, Exercise, Bone, CKD-MBD
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: jviana@ismai.pt
1Research Center in Sports Sciences, Health Sciences and Human
Development, CIDESD, University Institute of Maia, Av. Carlos Oliveira
Campos - Castelo da Maia, 4475-690 Maia, Portugal
Full list of author information is available at the end of the article
Cardoso et al. BMC Nephrology          (2020) 21:334 
https://doi.org/10.1186/s12882-020-01999-z
Background
Chronic kidney disease (CKD) is a worldwide health
problem with an estimated global prevalence of 11–13%
[1]. This prevalence is rising, driven by an aging popula-
tion and the increasing incidence of obesity, hyperten-
sion and diabetes [1]. In addition, most patients have an
increased risk of comorbidities [2] and all-cause cardio-
vascular premature death [3]. As a result, CKD repre-
sents an enormous economic burden for healthcare
systems worldwide with drastic personal health conse-
quences [1]. Patients suffering from CKD frequently de-
velop mineral and bone disorders (MBD) due to
systemic alterations induced by the disease [4]. This syn-
drome has been associated with the spectrum of renal
osteodystrophy [4], vascular calcifications, abnormalities
in bone mineralisation and turnover [5], increased bone
fractures [4], as well as increased morbidity and mortal-
ity, resulting in a diminished quality of life [6]. Thus,
CKD-MBD encompasses a wide spectrum of clinical dis-
orders such as alterations in mineral and bone metabol-
ism [6], which are in turn associated with abnormalities
in calcium, parathyroid hormone (PTH), phosphate or
vitamin D metabolism [7]. For instance, reduced levels
of vitamin D and osteocalcin (OC) carboxylation, and el-
evated serum PTH and fibroblast growth factor 23
(FGF-23) are key risk factors for bone disease [8]. PTH
and FGF-23 are the main regulating hormones of bone
integrity and mineral homeostasis [2].
Bone is a dynamic tissue which is constantly undergo-
ing remodelling [9], a process that mediates the balance
between bone formation and resorption to maintain
bone health and skeleton integrity [10]. However, in
CKD-MBD the rate of bone resorption exceeds the rate
of bone formation, resulting in loss of bone quantity and
quality, which consequently contributes to bone strength
loss [10].
Different physical activities, including high-impact
weight-bearing exercise, multi-directional weight-
bearing exercise, or resistance exercise have been
pointed as potentially able to stimulate resident osteo-
cytes to yield signalling molecules that regulate bone for-
mation and bone resorption [11, 12]. In addition,
substantial evidence supports that physical activity (PA)
and exercise interventions are effective in improving
bone health across all ages [13, 14]. Although different
exercise interventions (varying on type, intensity, fre-
quency, and duration) have been extensively explored in
healthy and osteoporotic populations [13, 15], the im-
pact of PA and exercise on bone health in CKD patients
is less well-established. As there has been no definitive
synthesis of these studies, the current systematic review
makes a major contribution to research through the in-
clusion of observational and experimental studies, in
order to explore the impact of different forms of
mechanical loading on different imaging and biochem-
ical bone outcomes in CKD. Thus, the purpose of the
present systematic review is to examine (1) the associa-
tions between PA and bone-related outcomes and (2)
the effects of different exercise interventions on bone-
related outcomes in CKD patients.
Methods
Eligibility criteria
The inclusion criteria for this systematic review were: (1)
observational studies, or randomized controlled trials
(RCTs), or non-randomized controlled trials (non-
RCTs); (2) reported measures of PA or implemented an
exercise intervention as the only intervention; (3) re-
ported data on one or more of the following bone out-
comes: bone density, geometry, microarchitecture, and
biomarkers of bone turnover; (4) adult CKD patients
(age ≥ 18 years old); and (5) CKD stage 3 to 5, including
patients under dialysis or kidney transplant recipients.
We did not include review articles, editorials, confer-
ence abstracts or animal-based trials. Studies published
in non-English-language were also not included due to
potential errors in the translation and interpretation of
findings.
Bone parameters were defined as areal bone mineral
density (BMD) or bone mineral content (BMC) or T-
score measured with dual X-ray absorptiometry (DXA),
bone macro- and micro-structure measured by 3D im-
aging techniques [quantitative computerized tomography
(QCT) and magnetic resonance imaging (MRI)], and
quantitative ultrasound (QUS) measurements of bone
density that included broadband ultrasound attenuation
(BUA) and the speed of sound (SOS). All skeletal sites
were considered. Bone outcomes included any forma-
tion, resorption and regulators markers of bone turnover
measured using any detection technique.
Bone outcomes based on conventional radiography
and bone biopsies were not included.
Search strategy and data source for studies identification
This systematic review is in accordance with the Pre-
ferred Reporting Items for Systematic Reviews and
Meta-Analyses: The PRISMA Statement guidelines
(Additional file 1) [16]. A computer search of databases
was conducted on EBSCO, Web of Science and Scopus
up to May 2019. The search terms used were: “CKD”,
“dialysis”, “renal function”, “glomerular filtration rate”,
“hemodialysis”, “renal”, “bone”, “exercise”, “physical ac-
tivity” (supplementary search strategy in Additional file 2).
At this stage, there were no limits on the search, such
as, language, animal and human-based study, or age.
Hand searching on Google Scholar was also performed
to identify possible missed studies in database search.
The reference lists of all the included studies have also
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been examined to identify any potential missed studies.
Afterwards, all the duplicate data were identified and re-
moved through the use of a reference management soft-
ware (EndNote®, version X7.8).
Data extraction
Data extraction was completed using a spreadsheet to
record information on a range of characteristics of each
study, including: first author and publication year, coun-
try, study design, sample size, type of population (stage
of CKD), outcomes measured, description of PA assess-
ment, description of the exercise intervention (for RCTs
and non-RCTs) and main results for each outcome. Data
were independently extracted by two review authors
(DC and EAM) and in case of missing or unclear infor-
mation, the authors of the included studies were con-
tacted for further details.
Methodological quality
The risk of bias of the included studies was assessed
using an adapted version of a modified Newcastle-
Ottawa Scale (NOS) tool for observational studies [17]
and the Cochrane Collaboration tool for the experimen-
tal studies [18]. The NOS includes the following five do-
mains: methods for the selection of participants
(selection bias), methods to control for confounding
(performance bias), statistical methods (detection bias),
methods of measuring outcome variables (information
bias), and subject follow-up (attrition bias for longitu-
dinal studies). Instead of using the scale 0 (for high risk
of bias), 1 (for mostly no), 2 (for mostly yes) and 3 (for
low risk of bias) as previously described [19], judgements
were categorized as ‘low risk’ of bias, ‘moderate risk’ of
bias, ‘high risk’ of bias or ‘unclear or unknown risk’ of
bias following our adapted version (Additional file 3).
The Cochrane risk of bias tool [18] addresses the follow-
ing six domains: selection bias (random sequence gener-
ation and allocation concealment), performance bias
(blinding of participants and personnel), detection bias
(blinding of outcome assessment), attrition bias (incom-
plete outcome data), reporting bias (selective reporting)
and other bias. For each entry, judgements were catego-
rized as ‘low risk’ of bias, ‘high risk’ of bias, or ‘unclear
risk’ of bias.
Fig. 1: Flow diagram of studies
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Two authors (DC and EAM) independently scored
each of the included articles and discrepancies were re-
solved through discussion until consensus was met.
Results
Included studies
Figure 1 shows the flowchart of the search and selection
process. A total of 2440 articles were identified by the
search strategy. After removing duplicate records, the ti-
tles, keywords and abstracts of 654 articles were ana-
lyzed and 18 relevant articles were identified for full text
review. From those, 13 studies fulfilled the inclusion cri-
teria and were included in our qualitative synthesis.
Studies were classified based on inherent purpose and
design features in observational (n = 6) or experimental
(n = 7).
Characteristics of the observational studies
The age range of our analytical sample in the observa-
tional studies was between 19 and 85 years old, mostly
representing middle-aged adults and older adults. The
characteristics of the included six observational studies
[20–25] are presented in Table 1. Four studies had a
cross-sectional design [20, 22, 24, 25], and two had a
longitudinal design [21, 23] with an observational period
of 12 and 24 months, respectively. Only one study had a
multi-centre design [23]. Regarding patients characteris-
tics, four reports recruited patients under haemodialysis
(HD) treatment [22–25] and two studies were performed
on kidney transplant patients [20, 21]. Sample size from
individual studies ranged from 32 to 115 patients, and
the overall sample size was 367 participants. Median age
of participants was 56 years (based on the reported mean
age), which varied from 19 to 85 years.
The most common method to assess PA was the use
of self-report questionnaires [20–23], while objective
measures were only captured in two studies [24, 25],
using triaxial pedometry and triaxial accelerometry,
respectively.
Except for one cross-sectional study in HD patients
[24], areal BMD (g/cm2) was measured trough DXA in
all included observational studies. Only one study also
used QCT, a 3D imaging technique, to assess total volu-
metric BMD (g/cm3) at the proximal femur and spine,
and cortical or trabecular mass (g) and volume (cm3) at
the proximal femur [23]. Most studies measured areal
BMD at more than one skeletal site. Lumbar spine BMD
was assessed in all studies, while proximal femur was
assessed in two of these studies [20, 23], total body
BMD was measured in two studies [20, 25] and one
Table 1 Characteristics of the observational studies






Bone biomarkers PA assessment method Results BMD Results Bone
biomarkers
Dolgos et al. 2008 [20]
(Cross-sectional)
Norway n = 108 (68%)
Kidney Transplant
DXA – Lunar (LS,
proximal femur both
sides, and total body)
iPTH Self-report questionnaire
Physical active vs. physical
Inactive (defined as regular
weight-bearing physical
exercise performed at least








Huang et al. 2009 [22]
(Cross-sectional)






Total weekly exercise time
(min/week): regular exercise
(yes or no), exercise type








Morishita et al. 2014 [24]
(Cross-sectional)










Ota et al. 1997 [25]
(Cross-sectional)












with total body BMD





Groth et al. 1995 [21]
(Longitudinal - 2-year
follow-up)
Germany n = 115 (61%)
Kidney Transplant












Malluche et al. 2017 [23]
(Longitudinal - 1-year
follow-up)














ALP Alkaline Phosphatase, BALP Bone-specific Alkaline Phosphatase, BMD Bone Mineral Density, DKK1 Dickkopf-related protein 1, DXA Dual-energy X-ray
absorptiometry, FGF-23 Fibroblast Growth Factor 23, FN Femoral Neck, HD Haemodialysis, iPTH Intact Parathyroid Hormone, LS Lumbar Spine, OC Osteocalcin, PA
Physical Activity, P1NP Procollagen type I N-terminal Propeptide, TRAP-5b Tartrate-resistant acid phosphatase 5b
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study also measured femoral neck BMD [22]. In addition
to imaging-derived bone parameters, different biochem-
ical markers of bone metabolism were measured in all
observational studies included in this review. Bone for-
mation markers included alkaline phosphatase (ALP)
[21, 22, 25], bone-specific alkaline phosphatase (BALP)
[23, 24], OC [21, 25] and procollagen type I N-terminal
propeptide (P1NP) [23] and intact P1NP (iP1NP) [24].
Whereas, one or more studies included data on bone re-
sorption markers such as sclerostin [23], dickkopf-
related protein 1 (DKK1) [23] and tartrate-resistant acid
phosphatase isoform 5b (Trap-5b) [23–25]. In addition,
FGF-23, a local factor in bone remodelling that stimu-
lates bone formation and resorption, was also assessed
in one study [23]. Finally, intact-PTH (iPTH) was re-
ported in all studies.
Characteristics of the experimental studies
The age range of our analytical sample in the experi-
mental studies was between 27 and 76 years old, mostly
representing middle-aged adults and older adults.
We identified five RCTs [26–30] and two non-RCTs
[31, 32] aiming to examine the effects of exercise on
bone parameters, which are described in detail in
Table 2. The sample size of the individual studies varied,
ranging between 13 and 52 subjects, and the overall
sample size was 215 patients. The median value of the
mean age was 52 years and ranged between 27 to 76
years old. Participants were mostly HD patients; only
one study included CKD stage 3–4 patients [27], and an-
other study included subjects with history of kidney
transplantation [26]. All outcomes were measured at
baseline and at the end of each intervention period, cor-
responding to 8 weeks [29], 12 weeks [26, 28, 30], and
24 weeks [27, 31, 32]. All exercise sessions were super-
vised by a certified professional, except the home-based
exercise trial that was weekly supervised [27]. The most
common type of exercise training was resistance exer-
cise, usually performed during dialysis (intradialytic ex-
ercise) three times per week [29–32]. Only one study
performed resistance exercise for kidney transplant pa-
tients [26]. In addition, two studies performed aerobic
exercise interventions, three times per week [27, 28],
and in one study [28] the aerobic exercise was per-
formed during dialysis.
Except for two experimental studies with no imaging-
derived bone parameters [27, 29], all other five studies mea-
sured BMD through DXA devices [26, 28, 30–32]. Two
studies reported T-score values [31] and BMC [30] from
total body scans. All other studies reported DXA-derived
outcomes from two or more skeletal sites. Areal BMD was
reported for lumbar spine in three studies [26, 28, 31], for
proximal femur in two studies [26, 31], and for femoral
neck in two studies [28, 31]. One study reported only the
T-score values for lumbar spine, proximal femur, femoral
neck and total body [31]. In addition to imaging-derived
bone parameters, different biochemical markers of bone
metabolism were measured in five experimental studies
[27–29, 31, 32], including the following markers of bone
formation: ALP [27], BALP [29], and OC [27, 32]; while
markers of bone resorption included sclerostin [27, 29],
Trap-5b [27], and osteoprotegerin (OPG) [32]. Other bio-
markers of bone health were also reported, including osteo-
pontin (OPN) [32], iPTH [28, 29, 32] and PTH [27, 31].
Risk of bias in the observational studies
In total, six observational studies were examined in the
present review. From these, overall assessment showed
that one study had low [20] and another had moderate
[23] risk of bias, with the remaining revealing high risk
of bias [21, 22, 24, 25], as seen in Additional file 4. Fur-
thermore, all studies examined bone biomarkers and
BMD as the main outcomes, except for Morishita et al.,
2014 [24], and the summary assessment for outcome
replicates the overall summary assessment for all obser-
vational studies.
Examining each domain separately, high risk is attrib-
uted to bias in Selection and bias in Performance only.
All other domains were rendered as low risk of bias.
Risk of bias in the experimental studies
This present review has examined seven experimental
studies. Determination of the summary of overall risk of
bias in each study shows that from these, three studies
were judged to have high risk of bias [30–32], whereas
the remaining four studies [26–29] are classified as un-
clear risk of bias (Additional file 5). Additionally, when
examining the risk of bias for outcome, risk of bias was
unclear [26, 28] and high [30, 31] in the four studies that
examined BMD. Bone biomarkers have been examined
in five of the seven experimental studies, with overall
unclear [27–29] and high [31, 32] risk of bias observed.
On the other hand, when examining each domain in-
dividually (i.e. risk of bias across studies), Reporting and
Attrition bias were judged as low risk, whereas all other
domains may be interpreted as having unclear risk of
bias.
Association between physical activity and bone outcomes
(observational studies)
Based on cross-sectional studies results, higher PA was
associated with higher DXA-derived areal BMD (g/cm2)
measured at different skeletal sites. Associations were
more consistent for total body [20, 25] and femoral neck
[22], but only three studies explored these outcomes.
Only one of the three cross-sectional studies that mea-
sured lumbar spine BMD in HD patients found a signifi-
cant association with exercise duration (min/week) [22].
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Two longitudinal studies reported the association be-
tween PA and bone mass changes, and findings were in-
consistent. Only one study explored this association with
proximal femur bone loss (areal BMD, cortical and tra-
becular volume and mass) and found no evidence of as-
sociation with PA [23]. Similarly, to cross-sectional data,
estimates of association between PA and lumbar spine
bone loss pointed for inconsistent results. A positive cor-
relation between estimated energy expenditure during
sports with bone gain (r = 0.2, P < 0.05) was reported in
kidney transplant patients [21], while a lack of
association was reported with two-year spinal BMD loss
measured by QCT or DXA [23] in HD patients. Finally,
the results for biochemical markers of bone metabolism
were consistent, with all cross-sectional and longitudinal
studies reporting no significant associations. In sum-
mary, cross-sectional data shows positive associations
between PA and BMD at femoral neck, lumbar spine
and total body. Evidence from longitudinal studies was
conflicting, with only one study supporting a positive as-
sociation between PA and lumbar spine BMD gain.
Based on all included observational studies, PA is not
Table 2 Characteristics of the experimental studies








Exercise intervention Results BMD Results Bone
biomarkers
Eatemadololama
et al. 2017 [26]
(RCT)









(10 min stretching exercises,
10 min walking, 10 min cycling,
20 min RE for UL, 20 min RE for
LL; RE intensity 50% of 1RM






















Aerobic exercise (40–60% of
maximum VO2; 30 min;
3 days/week; 24 weeks)
– EG: ↑ ALP
CG: = all
biomarkers









DXA (LS and FN) iPTH Intradialytic aerobic exercise
(12–15 BPES; 30 min; 3 days/
week; 12 weeks)
EG: = all bone sites
CG: = all bone
sites



















exercise (60–70% of 3RM;
4 exercises; 3 days/week;
8 weeks)
– EG: ↑ BALP
CG: = all
biomarkers









(Total body - BMC)
– Intradialytic resistance exercise
(60% of 1RM; 40-50min;
3 days/week; 12 weeks)
EG: = total body
BMC
CG: = total body
BMC
EG vs CG: ↑ BMC
(favouring EG)














(60–70% of 1RM; 4 exercises;
3 sets; 10 repetitions; 3 days/
week; 24 weeks)
– EG: ↑ OPG
CG: = all
biomarkers









DXA – Lunar (FN, LS,
proximal femur and
total body)
PTH Intradialytic resistance exercise
(60–70% of 1RM; 4 exercises;
3 sets; 10 repetitions; 3 days/
week; 24 weeks)
EG: ↑ femoral neck
CG: = all bone
sites





EG vs CG: no
comparison
ALP Alkaline Phosphatase, BALP Bone-specific Alkaline Phosphatase, BMD Bone Mineral Density, BMC Bone Mineral Content, BPES Borg Perceived Exertion Scale, CG
Control Group, DXA Dual-energy X-ray absorptiometry, EG Exercise Group, FN Femoral Neck, HD Haemodialysis, iPTH Intact Parathyroid Hormone, LL Lower Limb,
LS Lumbar Spine, OC Osteocalcin, OPG Osteoprotegerin, OPN Osteopontin, P1NP Procollagen type I N-terminal Propeptide, PTH Parathyroid Hormone, RE
Resistance Exercise, RM One Repetition Maximum, TRAP-5b Tartrate-resistant acid phosphatase 5b, UL Upper Limb, ↑ significant increase, = no change, ↓
significant decrease
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related with bone metabolism biomarkers in CKD
patients.
Exercise-related effects on bone outcomes (experimental
studies)
Only one study explored the effect of aerobic exercise
(intradialytic) on BMD and found no significant differ-
ences at both lumbar spine and femoral neck areal BMD
in the exercise and control groups after 12 weeks [28].
Of note, this study reported a significant bone loss at the
femoral neck in the control group compared to the exer-
cise group.
Data from trials evaluating the effects of resistance ex-
ercise protocols reported inconsistent results on areal
BMD at different skeletal sites. Taken together, results
suggested an increase – particularly at the femoral neck
and proximal femur [26, 31] – or no significant changes
in areal BMD after resistance exercise training, mostly at
lumbar spine and total body [26, 30, 31].
Based on the results of the five studies reporting data on
biochemical markers of bone metabolism, only three stud-
ies found a significant effect of exercise in a limited num-
ber of bone biomarkers linked to bone formation (ALP
and BALP) and bone resorption (OPG) [27, 29, 32]. The
significant increase in ALP levels were observed only in
the exercise groups after 24 weeks of aerobic exercise in
CKD stages 3–4 patients [27] and in BALP after 8 weeks
of resistance exercise in HD patients [29]. In addition, 24
weeks of intradialytic resistance exercise significantly im-
proved OPG levels, while no changes were observed in the
control group [27]. Levels of OC, Trap-5b and OPN were
consistently unchanged following any type of exercise
intervention [27, 29, 32].
Discussion
Summary of the main evidence
The current systematic review showed that PA may be
associated with BMD in HD and kidney transplant pa-
tients. However, these findings are mostly supported by
cross-sectional data showing positive associations be-
tween PA and BMD, despite evidence from longitudinal
studies was contradictory (i.e. the analysis of observa-
tional studies proposes that PA is not related with bone
metabolism biomarkers in CKD patients). Evidence from
the experimental studies highlights exercise interven-
tions as beneficial to improve bone health in CKD stages
3–4, HD and kidney transplant patients improve bone
health in CKD stages 3–4, HD and kidney transplant pa-
tients, with resistance exercise training drawing more
solid conclusions than aerobic exercise in its potential
effectiveness in improving BMD and bone markers in
HD and kidney transplant patients.
Overall completeness and applicability of the evidence
The overall patients included in this review were re-
cruited from seven different countries. Despite such var-
iety, ethnicity was poorly reported, and most patients
were male (range between 43 and 71%) The individual
studies included in the current review are characterized
by small sample sizes and mostly completed in HD pa-
tients, thus the summarized data may not apply to a
broader adult population with CKD. Additionally, the
methods used to assess PA and the exercise interven-
tions varied substantially. Despite such lack of substan-
tial studies, exercise is a non-pharmacological strategy
widely recognized as a vital mechanical stimulus for the
development and maintenance of optimal bone strength
throughout life and the main results of this review point
towards a positive effect of exercise on bone health in
CKD patients, strengthening its usefulness and applic-
ability within a clinical setting.
Quality of the evidence
This systematic review included 13 studies, six observa-
tional (n = 367) and seven experimental (n = 215) studies.
However, some of the included studies have methodo-
logical limitations that may limit their internal validity.
PA was mainly assessed by self-report questionnaires
and was poorly described. Regarding our main out-
comes, most bone density data was measured with DXA
scans, which do not distinguish between trabecular and
cortical bone compartments and provide no measure of
bone geometry. This may be interpreted as a limitation,
as decreased bone strength in CKD patients is associated
with the loss of both bone quantity (BMD) and quality
(such as the bone microarchitecture) [10]. Furthermore,
it has been proposed that DXA may erroneously attri-
bute low BMD values in individuals with low volumetric
density, due to a less accurate detection of bone edges,
therefore underestimating BMD [33]. In addition, three
studies had follow-up lengths of less than 16 weeks. As
bone formation biologically takes around 4months (ap-
proximately 16 weeks) to occur [34], interventions com-
pleted in shorter periods may not reliably detect skeletal
changes with this imaging tool.
Additionally, the experimental studies scrutinised in
this review examined the effects of different types of ex-
ercise, durations and intensities, and had an unclear risk
of bias for most key domains. As an example, two of the
experimental studies presented, despite a similar design
(i.e.12-week, intradialytic exercise program), used differ-
ent exercise modes (one aerobic [28], the other resist-
ance [30]) and intensities, which may explain the
different changes in BMD outcomes and the observed
distinct risk of bias (unclear and high, respectively).
Therefore, results should be interpreted with caution.
Taken together, these methodological limitations impose
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some constraints to the quality of evidence summarized
in the present review.
Potential bias in the review process
A comprehensive search of journals in several databases
was conducted and all published trials were identified.
Different study designs were included in the review (i.e.
longitudinal, cross-sectional, RCT and non-RCT), and
all stages of the CKD as well as kidney transplant pa-
tients were considered. Additionally, the methodological
quality of each study was corroborated by another re-
viewer. Some authors were contacted to clarify specific
details required during data extraction and to ascertain
if any newer data were available since publication. How-
ever, potential bias in this review exist. Unpublished tri-
als were not included, as we did not conduct
comprehensive searches of conference databases, and al-
though we did not limit the searches to a particular lan-
guage, only English language studies were included. We
are unaware of any other potential biases in the review
process.
Agreements and disagreements with other studies or
reviews
The link between PA and exercise with bone health has
been extensively studied and summarized in several re-
views [14, 15, 34, 35]. However, there are no previous re-
views exploring this topic in CKD patients. Our
systematic review demonstrated that only 3 studies in a
total of 6 included in the review, suggests a positive as-
sociation between PA and BMD at femoral neck and
lumbar spine in HD [22, 25] and total body also in HD
[25] and kidney transplant patients [20]. In fact, these
findings are in agreement with other reviews in young
adults [36] and post-menopausal women [37], suggesting
that similar positive effects would also be expected in
CKD patients. However, the lack of significant associa-
tions described in the current review, may be explained
by the possible limited reliability of PA questionnaires to
assess bone-specific loading exercise rather their inten-
sity [38–40]. Previous studies support a relationship be-
tween PA and some bone markers such as BALP, OC in
healthy subjects [41] and OPG in breast cancer [42] and
post-menopausal [43] women, which is not corroborated
by our present review in CKD patients.
Exercise trials in CKD patients were mostly based on
resistance training protocols. This type of exercise has
been shown to have a significant osteogenic effect [12].
Our review support that resistance exercise may be more
effective in improving bone health outcomes than aer-
obic exercise, which is in agreement with the main lit-
erature in older adults and healthy adults [14, 44, 45].
Intradialytic resistance exercise training revealed to be
effective in improving BMD at femoral neck and total
body BMC in HD patients [30, 31], while resistance ex-
ercise performed by kidney transplant patients only im-
proved proximal femur BMD [26]. Several systematic
reviews in non-CKD subjects reported that high impact,
resistance exercise or combined resistance with high im-
pact exercise induced significant improvements in BMD
at femoral neck of premenopausal women and older
adults [13, 35, 45], which is in line with some of the re-
sults of this review.
A positive effect of resistance exercise on the regula-
tion of the bone formation and resorption biomarkers in
healthy subjects has been described [46]. Our findings
also support that resistance exercise may elicit positive
changes in bone metabolism in CKD patients, particu-
larly in OPG [32], ALP [27] and BALP [29]. Of note, the
impact of exercise in bone metabolism was not signifi-
cant in all measured biomarkers (PTH, iPTH, TRAP5b,
sclerostin, OC, OPN), which may be explained by differ-
ences in the detection of some biomarkers, measurement




This is the first systematic review on observational and
experimental studies to analyse the association of PA
and exercise with bone outcomes and health in CKD pa-
tients. The main goal of the current review was to better
inform about the association of PA with bone health and
the exercise-related effects on bone health outcomes in
CKD patients, and consequently to help improving exer-
cise prescription recommendations.
Although the evidence summarized in this review on
PA and bone health is limited, clinicians and exercise
physiologists should advise CKD patients to increase
their PA levels as it may be related with higher BMD,
apart from other physiological and psychological benefits
that may be derived from increasing PA.
Currently, CKD patients are advised to perform resist-
ance exercise [47, 48] even though the exercise guide-
lines vary depending on the referenced organisation.
However, most trials included in our review poorly de-
scribed the resistance exercise protocols in terms of the
exercise characteristics (i.e. mode, intensity, duration
and frequency), and progression. The overall effects re-
ported in this review pointed to an increase of BMD at
femoral neck and proximal femur, which may prevent
and/or decrease the risk of hip fractures. In addition,
based on the current evidence, resistance exercise may
increase OPG levels, which may be an indicator of better
bone mass and strength. OPG protects bone from exces-
sive resorption [49] and was recently associated with
bone fractures in CKD patients [50]. Currently, there are
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no support for a positive effect of aerobic exercise in
OPG levels [51].
This review included a limited number of resistance
exercise trials; therefore, the summarized data is insuffi-
cient to support any recommendation on resistance ex-
ercise protocols as a more efficient intervention to
improve bone health in CKD patients. Aerobic exercise
is also broadly recommended for CKD patients [48], as
it may be associated with better exercise capacity and
physical functioning [52, 53]. Based on evidence from
previous reviews in healthy adults, aerobic exercise of
moderate intensity and low impact (such as walking) has
limited effects on bone parameters [54–56]. Similar re-
sults should be expected in CKD patients.
Implications for future research
This systematic review demonstrated that studies explor-
ing this topic are currently lacking. Future studies should
implement exercise interventions with a minimum dur-
ation of 16 weeks, using more sophisticated imaging
techniques such as QCT or MRI, and including a set of
key bone metabolism biomarkers of bone formation, re-
sorption and CKD-MBD markers, as they quickly reveal
changes in bone turnover. Useful bone biomarkers in-
clude: Type I Collagen Cross-Linked C-Telopeptide,
P1NP ALP, BALP, OC, Trap-5b, Cathepsin K, sclerostin,
DKK1, OPG, receptor activator of nuclear factor kappa-
Β ligand (RANKL), RANKL/OPG ratio, among enzymes
and nonenzymatic peptides derived from the cellular
and noncellular compartments of bone.
Unfortunately, our summary of results showed incon-
sistent findings that were mostly based on small trials;
thus, studies with appropriate statistical power are
needed. In addition, most of the studies included in this
review failed to describe the methods used to assess
daily PA levels and the details of the exercise protocols
and equipment. For instance, the use of elastic bands
makes harder to define intensity and training progres-
sion. More RCTs exploring resistance exercise, aerobic,
and combined exercise interventions exploring different
intensities, durations, and in all spectrum of CKD dis-
ease, including pre-dialysis patients are clearly needed.
Finally, the acute effects of exercise on bone health out-
comes (mass quantity and quality, strength, and bio-
markers) should be investigated.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12882-020-01999-z.
Additional file 1. PRISMA Checklist. Twenty-seven-item checklist
reporting of a systematic review.
Additional file 2. Search strategy. Report of a full electronic search
strategy for EBSCO database.
Additional file 3. Adapted Newcastle-Ottawa Scale. Adapted scale to as-
sess risk of bias of 7 observational studies included.
Additional file 4. Risk of bias summary of observational studies. Figure
showing the summary of the risk of bias analysis observed in 7
observational studies.
Additional file 5. Risk of bias summary of experimental studies. Figure
showing the summary of the risk of bias analysis observed in 6
experimental studies.
Abbreviations
ALP: Alkaline Phosphatase; BALP: Bone-specific Alkaline Phosphatase;
BMC: Bone Mineral Content; BMD: Bone Mineral Density; BUA: Broadband
Ultrasound Attenuation; CKD: Chronic Kidney Disease; DKK1: Dickkopf-related
Protein 1; DXA: Dual X-ray absorptiometry; FGF-23: Fibroblast Growth Factor
23; HD: Haemodialysis; iP1NP: intact P1NP; iPTH: intact PTH; MBD: Mineral
and Bone Disorders; MRI: Magnetic Resonance Imaging; Non-RCT: Non-
randomized Control Trials; NOS: Modified Newcastle-Ottawa Scale;
OC: Osteocalcin; OPG: Osteoprotegerin; OPN: Osteopontin; P1NP: Procollagen
type I N-terminal Propeptide; PA: Physical Activity; PTH: Parathyroid
Hormone; QCT: Quantitative Computerized Tomography; QUS: Quantitative
Ultrasound; RANKL: Receptor Activator of Nuclear Factor Kappa-Β Ligand;
RCTs: Randomized Control Trials; SOS: Speed of Sound; Trap-5b: Tartrate-




Research idea and study design: DC, EAM, JLV; data collection: DC; data
analysis and interpretation: DC, EAM, JLV; manuscript preparation: DC, EAM,
DVL, AF, LAB, AS, JLV. Each author contributed important intellectual content
during manuscript drafting or revision and accepts accountability for the
overall work by ensuring that questions pertaining to the accuracy or
integrity of any portion of the work are appropriately investigated and
resolved. All authors have read and approved the final version.
Funding
Research Center in Sports Sciences, Health Sciences and Human
Development, CIDESD, is supported by the Portuguese Foundation of
Science and Technology (UID/DTP/04045/2019). DC is supported by a
Portuguese Foundation of Science and Technology doctoral grant (SFRH/BD/
138940/2018).
Availability of data and materials
The datasets generated during and/or analysed during the current study are
available from the corresponding author on reasonable request.





The authors declare that they have no competing interests.
Author details
1Research Center in Sports Sciences, Health Sciences and Human
Development, CIDESD, University Institute of Maia, Av. Carlos Oliveira
Campos - Castelo da Maia, 4475-690 Maia, Portugal. 2Department of
Nephrology, Curry Cabral Hospital, Lisbon, Portugal. 3Leicester Kidney
Lifestyle Team, Department of Health Sciences, University of Leicester,
Leicester, UK.
Cardoso et al. BMC Nephrology          (2020) 21:334 Page 9 of 11
Received: 26 December 2019 Accepted: 31 July 2020
References
1. Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al.
Global prevalence of chronic kidney disease – a systematic review and
meta-analysis. PLoS One. 2016;11(7):e0158765.
2. Romagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M, et al.
Chronic kidney disease. Nat Rev Dis Prim. 2017;3:17088.
3. Stel VS, Brück K, Fraser S, Zoccali C, Massy ZA, Jager KJ. International
differences in chronic kidney disease prevalence: a key public health and
epidemiologic research issue. Nephrol Dial Transplant. 2017;32(2):ii129–35.
4. Bello AK, Alrukhaimi M, Ashuntantang GE, Basnet S, Rotter RC, Douthat WG,
et al. Complications of chronic kidney disease: current state, knowledge
gaps, and strategy for action. Kidney Int Suppl. 2017;7(2):122–9.
5. Martin KJ, González EA. Metabolic bone disease in chronic kidney disease. J
Am Soc Nephrol. 2007;18(3):875–85.
6. Cozzolino M, Ureña-Torres P, Vervloet MG, Brandenburg V, Bover J,
Goldsmith D, et al. Is chronic kidney disease-mineral bone disorder (CKD-
MBD) really a syndrome? Nephrol Dial Transplant. 2014;29(10):1815–20.
7. Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease.
Lancet. 2017;389(10075):1238–52.
8. Zoccali C, Vanholder R, Massy ZA, Ortiz A, Sarafidis P, Dekker FW, et al. The
systemic nature of CKD. Nat Rev Nephrol. 2017;13(6):344–58.
9. Raggatt LJ, Partridge NC. Cellular and molecular mechanisms of bone
remodeling. J Biol Chem. 2010;285(33):25103–8.
10. Zheng C-M, Zheng J-Q, Wu C-C, Lu C-L, Shyu J-F, Yung-Ho H, et al. Bone
loss in chronic kidney disease: quantity or quality? Bone. 2016;87:57–70.
11. Russo CR. The effects of exercise on bone. Basic concepts and implications
for the prevention of fractures. Clin Cases Miner Bone Metab. 2009;6(3):223–8.
12. Hong AR, Kim SW. Effects of resistance exercise on bone health. Endocrinol
Metab. 2018;33(4):435–44.
13. Marques EA, Mota J, Carvalho J. Exercise effects on bone mineral density in
older adults: a meta-analysis of randomized controlled trials. Age. 2012;34(6):
1493–515.
14. Santos L, Elliott-Sale KJ, Sale C. Exercise and bone health across the lifespan.
Biogerontology. 2017;18(6):931–46.
15. Harding AT, Beck BR. Exercise, osteoporosis, and bone geometry. Sports.
2017;5(2):29.
16. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al.
The PRISMA statement for reporting systematic reviews and meta-analyses
of studies that evaluate health care interventions: explanation and
elaboration. PLoS Med. 2009;6(7):e1000100.
17. Perera S, Eisen R, Bawor M, Dennis B, de Souza R, Thabane L, et al.
Association between body mass index and suicidal behaviors: a systematic
review protocol. Syst Rev. 2015;4:52.
18. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al.
The Cochrane Collaboration’s tool for assessing risk of bias in randomised
trials. BMJ. 2011;343:5928.
19. Bawor M, Dennis BB, Bhalerao A, Plater C, Worster A, Varenbut M, et al. Sex
differences in outcomes of methadone maintenance treatment for opioid
use disorder: a systematic review and meta-analysis. CMAJ. 2015;3(3):344–51.
20. Dolgos S, Hartmann A, Bønsnes S, Ueland T, Isaksen GA, Godang K, et al.
Determinants of bone mass in end-stage renal failure patients at the time
of kidney transplantation. Clin Transpl. 2008;22(4):462–8.
21. Groth WH, Mundinger FA, Rasenack J, Speidel L, Olschewski M, Exner VM,
et al. Bone loss after kidney transplantation: a longitudinal study in 115 graft
recipients. Nephrol Dial Transplant. 1995;10(11):2096–100.
22. Huang G-S, Chu T-S, Lou M-F, Hwang S-L, Yang R-S. Factors associated with
low bone mass in the hemodialysis patients - a cross-sectional correlation
study. BMC Musculoskelet Disord. 2009;10:60.
23. Malluche HH, Monier-Faugere M-C, Blomquist G, Davenport DL. Two-year
cortical and trabecular bone loss in CKD-5D: biochemical and clinical
predictors. Osteoporos Int. 2018;29(1):125–34.
24. Morishita Y, Kubo K, Miki A, Ishibashi K, Kusano E, Nagata D. Positive
association of vigorous and moderate physical activity volumes with skeletal
muscle mass but not bone density or metabolism markers in hemodialysis
patients. Int Urol Nephrol. 2014;46(3):633–9.
25. Ota S, Takahashi K, Taniai K, Makino H. Bone metabolism and daily physical
activity in women undergoing hemodialysis. Nihon Jinzo Gakkai Shi. 1997;
39(4):441–6.
26. Eatemadololama A, Karimi MT, Rahnama N, Rasolzadegan MH. Resistance
exercise training restores bone mineral density in renal transplant recipients.
Clin Cases Miner Bone Metab. 2017;14(2):157–60.
27. Gomes TS, Aoike DT, Baria F, Graciolli FG, Moyses RMA, Cuppari L. Effect of
aerobic exercise on markers of bone metabolism of overweight and obese
patients with chronic kidney disease. J Ren Nutr. 2017;27(5):364–71.
28. Liao M-T, Liu W-C, Lin F-H, Huang C-F, Chen S-Y, Liu C-C, et al. Intradialytic
aerobic cycling exercise alleviates inflammation and improves endothelial
progenitor cell count and bone density in hemodialysis patients. Medicine.
2016;95(27):e4134.
29. Marinho SMSDA, Mafra D, Pelletier S, Hage V, Teuma C, Laville M, et al. In
hemodialysis patients, intradialytic resistance exercise improves osteoblast
function: a pilot study. J Ren Nutr. 2016;26(5):341–5.
30. Rosa CSDC, Nishimoto DY, Souza GDE, Ramirez AP, Carletti CO, Daibem CGL,
et al. Effect of continuous progressive resistance training during
hemodialysis on body composition, physical function and quality of life in
end-stage renal disease patients: a randomized controlled trial. Clin Rehabil.
2018;32(7):899–908.
31. Marinho SM, Moraes C, Barbosa JEDSM, Carraro Eduardo JC, Fouque D,
Pelletier S, et al. Exercise training alters the bone mineral density of
hemodialysis patients. J Strength Cond Res. 2016;30(10):2918–23.
32. Marinho SM, Carraro Eduardo JC, Mafra D. Effect of a resistance exercise
training program on bone markers in hemodialysis patients. Sci Sports.
2017;32(2):99–105.
33. Pors Nielsen S, Kolthoff N, Bärenholdt O, Kristensen B, Abrahamsen B,
Hermann AP, et al. Diagnosis of osteoporosis by planar bone densitometry:
can body size be disregarded? Br J Radiol. 1998;71(849):934–43.
34. Dolan E, Varley I, Ackerman KE, Pereira RMR, Elliott-Sale KJ, Sale C. The bone
metabolic response to exercise and nutrition. Exerc Sport Sci Rev. 2020;
48(2):49–58.
35. Xu J, Lombardi G, Jiao W, Banfi G. Effects of exercise on bone status in
female subjects, from young girls to postmenopausal women: an overview
of systematic reviews and meta-analyses. Sports Med. 2016;46(8):1165–82.
36. Bielemann RM, Martinez-Mesa J, Gigante DP. Physical activity during life
course and bone mass: a systematic review of methods and findings from
cohort studies with young adults. BMC Musculoskelet Disord. 2013;14:77.
37. Muir JM, Ye C, Bhandari M, Adachi JD, Thabane L. The effect of regular
physical activity on bone mineral density in post-menopausal women aged
75 and over: a retrospective analysis from the Canadian multicentre
osteoporosis study. BMC Musculoskelet Disord. 2013;14:253.
38. Kim S, Baker BS, Sharma-Ghimire P, Bemben DA, Bemben MG. Association
between bone-specific physical activity scores and pQCT-derived measures
of bone strength and geometry in healthy young and middle-aged
premenopausal women. Arch Osteoporos. 2018;13(1):83.
39. Weeks BK, Beck BR. The BPAQ: a bone-specific physical activity assessment
instrument. Osteoporos Int. 2008;19(11):1567–77.
40. Farr JN, Lee VR, Blew RM, Lohman TG, Going SB. Quantifying bone-relevant
activity and its relation to bone strength in girls. Med Sci Sports Exerc. 2011;
43(3):476–83.
41. Alghadir AH, Gabr SA, Al-Eisa E. Physical activity and lifestyle effects on
bone mineral density among young adults: sociodemographic and
biochemical analysis. J Phys Ther Sci. 2015;27(7):2261–70.
42. Yao S, Zhang Y, Tang L, Roh JM, Laurent CA, Hong C-C, et al. Bone
remodeling and regulating biomarkers in women at the time of breast
cancer diagnosis. Breast Cancer Res Treat. 2017;161(3):501–13.
43. LaCroix AZ, Jackson RD, Aragaki A, Kooperberg C, Cauley JA, Chen Z, et al.
OPG and sRANKL serum levels and incident hip fracture in postmenopausal
Caucasian women in the women’s health initiative observational study.
Bone. 2013;56(2):474–81.
44. Guadalupe-Grau A, Fuentes T, Guerra B, Calbet JAL. Exercise and bone mass
in adults. Sports Med. 2009;39(6):439–68.
45. Bolam KA, van Uffelen JGZ, Taaffe DR. The effect of physical exercise on
bone density in middle-aged and older men: a systematic review.
Osteoporos Int. 2013;24(11):2749–62.
46. Maïmoun L, Sultan C. Effects of physical activity on bone remodeling.
Metabolism. 2011;60(3):373–88.
47. Medecine. AC of S. ACSM’s guidelines for exercise testing and prescription.
10th ed. 2017.
48. Smart NA, Williams AD, Levinger I, Selig S, Howden E, Coombes JS, et al.
Exercise & Sports Science Australia (ESSA) position statement on exercise
and chronic kidney disease. J Sci Med Sport. 2013;16(5):406–11.
Cardoso et al. BMC Nephrology          (2020) 21:334 Page 10 of 11
49. Carvalho C, Alves CM, Frazão JM. The role of bone biopsy for the diagnosis
of renal osteodystrophy: a short overview and future perspectives. J
Nephrol. 2016;29(5):617–26.
50. West SL, Lok CE, Jamal SA. Osteoprotegerin and fractures in men and
women with chronic kidney disease. J Bone Miner Metab. 2014;32(4):428–
33.
51. Marques EA, Wanderley F, Machado L, Sousa F, Viana JL, Moreira-Gonçalves
D, et al. Effects of resistance and aerobic exercise on physical function, bone
mineral density, OPG and RANKL in older women. Exp Gerontol. 2011;46(7):
524–32.
52. Young HML, March DS, Graham-Brown MPM, Jones AW, Curtis F, Grantham
CS, et al. Effects of intradialytic cycling exercise on exercise capacity, quality
of life, physical function and cardiovascular measures in adult haemodialysis
patients: a systematic review and meta-analysis. Nephrol Dial Transplant.
2018;33(8):1436–45.
53. Wang CJ, Johansen KL. Are dialysis patients too frail to exercise? Semin Dial.
2019;32(4):291–6.
54. Martyn-St James M, Carroll S. Meta-analysis of walking for preservation of
bone mineral density in postmenopausal women. Bone. 2008;43(3):521–31.
55. Gómez-Cabello A, Ara I, González-Agüero A, Casajús JA, Vicente-Rodríguez
G. Effects of training on bone mass in older adults: a systematic review.
Sports Med. 2012;42(4):301–25.
56. Ma D, Wu L, He Z. Effects of walking on the preservation of bone mineral
density in perimenopausal and postmenopausal women: a systematic
review and meta-analysis. Menopause. 2013;20(11):1216–26.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Cardoso et al. BMC Nephrology          (2020) 21:334 Page 11 of 11
